Browsing by Author "Kuznetsov, S."

Now showing 1 - 6 of 6
  • No Thumbnail Available
    ItemMetadata only
    Electrophysiological study of infant and adult rats under acute intoxication with fluoroacetamide.
    (Wiley, 2007) Kuznetsov, S.; Jenkins, R. O.; Goncharov, Nikolay V.
  • No Thumbnail Available
    ItemMetadata only
    Fluroacetate
    (Elsevier, 2009) Goncharov, Nikolay V.; Glashkina, L.; Savelieva, E. I.; Zinchenko, V.; Teplova, V. V.; Vinokurov, M.; Kuznetsov, S.; Mindukshev, I. V.; Avdonin, P.; Jenkins, R. O.; Radilov, Andrey S.
  • No Thumbnail Available
    ItemMetadata only
    Fluroacetate.
    (Elsevier, 2015) Goncharov, Nikolay V.; Savelieva, E. I.; Zinchenko, V.; Kuznetsov, S.; Mindukshev, I. V.; Vinokurov, M.; Avdonin, P.; Voitenko, Natalia G.; Ukolov, A.; Orlova, O. I.; Jenkins, R. O.; Kuznetsov, A.
    Action of fluoroacetate (FA) becomes apparent after a latent period, even after exposure to lethal doses. The best known representative of FA is its sodium salt. There are also series of fluorinated compounds which metabolism is connected with formation of FA. To reveal intoxications, adequate analytical procedures should be developed, as well as unequivocal biochemical, physiological and clinical signs of intoxication should be described. Also, new approaches to development of an effective therapy for treating acute intoxications by FA are highly important, because after many decades of toxicological studies on FA effective antidotes are not available. These and other points are the subjects of discussion in this chapter. Some old and new data are critically revised, together with presentation of the authors’ experimental results, the main theme of which is development of new and effective therapy for treating acute intoxication by FA.
  • No Thumbnail Available
    ItemMetadata only
    Russian VX
    (Elsevier Inc./Academic Press, 2020-04-27) Rembovskiy, V.; Savelieva, A.; Radilov, A.; Samchenko, N.; Karakashev, G.; Leninskiy, M.; Koryagina, N.; Kuznetsov, S.; Mindukshev, I.; Khlebnikova, N.; Jenkins, R. O.; Goncharov, N. V.
  • No Thumbnail Available
    ItemMetadata only
    Russian VX
    (Elsevier, 2015) Rembovskiy, V.; Radilov, Andrey S.; Savelieva, E. I.; Kuznetsov, S.; Mindukshev, I. V.; Prokofieva, Daria S.; Krivorotova, N.; Khlebnikova, N. S.; Jenkins, R. O.; Goncharov, Nikolay V.
    Presented in this chapter are data on the principal hydrolysis products of Russian VX (RVX) with excess and equimolar quantity of water, as well as a generalized list of compounds extracted from samples of construction materials of a former RVX production facility. Toxicokinetic experiments have been conducted to determine decrease of O-alkyl methylphosphonates in blood plasma of rats after i.m. administration of RVX. MS/MS peptide spectra obtained with commercially available human albumin incubated with RVX revealed covalent binding of RVX to Tyr 411 and Tyr150. A new covalent adduct of N,N-diethyl-2-aminoethanthiol (a RVX hydrolysis product) with blood plasma proteins has been detected by HPLC–MS/MS, and this can be another marker of exposure to RVX. New data on effects developed under chronic exposure of rats to RVX are presented: these are kinetic parameters of blood platelet aggregation and electrophysiology of Nervus tibialis. According to these data, morphofunctional changes at the level of the microcirculatory bed may prove to be a significant factor in the etiology of delayed effects.
  • No Thumbnail Available
    ItemMetadata only
    Russian VX: monitoring and toxicity
    (Elsevier, 2009) Radilov, Andrey S.; Rembovskiy, V.; Rybalchenko, I.; Savelieva, E. I.; Podolskaya, E.; Babakov, Vladimir N.; Ermolaeva, E. E.; Dulov, S.; Kuznetsov, S.; Mindukshev, I. V.; Shpak, A.; Krasnov, I.; Khlebnikova, N. S.; Jenkins, R. O.; Goncharov, Nikolay V.